A U.S. Centers for Disease Control and Prevention panel has approved the latest booster for COVID-19 as cases continue to rise amid the spread of t...
A U.S. Centers for Disease Control and Prevention panel has approved the latest booster for COVID-19 as cases continue to rise amid the spread of the virus’ omicron variants.
The panel approved the updated vaccine on Tuesday, universally recommending that everyone six months and older receive the shot, which more closely matches the currently circulating variants. CDC Director Mandy Cohen still needs to endorse the approval, but has previously said she expects the booster to roll out this month.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
CDC Panel Approves New COVID-19 Booster Amid Rapid Spread Of New 'Eris' SubvariantThe panel authorized updated Pfizer and Moderna vaccines that are expected to protect against the new omicron strains causing a surge in cases.
Leer más »
CDC advisory panel issues updated COVID shot guidanceThe latest vaccines from pharmaceutical companies Moderna and Pfizer/BioNTech target more recent variants of the virus.
Leer más »
COVID-19 vaccine: CDC panel recommends shots for ages 6 months and olderAmericans may soon be able to get an updated COVID-19 vaccine. Advisers to the Centers for Disease Control and Prevention on Tuesday endorsed the new shots for everyone 6 months of age and older.
Leer más »
CDC panel recommends updated COVID vaccines, shots could be ready this weekAdvisers to the Centers for Disease Control and Prevention on Tuesday endorsed the new COVID-19 shots for everyone 6 months of age and older. The vaccines could be available this week.
Leer más »
COVID Boosters BackedCDC panel of advisers supports broad rollout
Leer más »
US CDC contemplates who should get the new COVID shotsA U.S. Centers for Disease Control and Prevention (CDC) advisory panel is due on Tuesday to recommend whether the updated COVID-19 shots formulated by vaccine manufacturers should be given broadly or just to specific populations at higher risk during this fall's vaccination campaign.
Leer más »